Celestial Biolabs - Quaterly Results

29 Mar 2024 Evaluate
The Revenue for the quarter ended  December 2023 of Rs. 0.37 millions grew by 8.82 % from Rs. 0.34 millions.The Net Loss for the quarter ended December 2023 is Rs. -0.35 millions as compared to Net Loss of Rs. -1.54 millions of corresponding quarter ended December 2022 Operating profit Margin for the quarter ended December 2023 improved to -0.29% as compared to -1.46% of corresponding quarter ended December 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 0.37 0.34 8.82 0.96 1.31 -26.72 1.69 1.48 14.19
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT -0.29 -1.46 -80.14 -1.48 -3.14 -52.87 -5.41 -3.79 42.74
Interest 0.01 0.01 0.00 0.01 0.02 -50.00 0.02 0.00 0.00
PBDT -0.30 -1.47 -79.59 -1.49 -3.16 -52.85 -5.43 -3.79 43.27
Depreciation 0.05 0.07 -28.57 0.15 0.21 -28.57 0.28 0.30 -6.67
PBT -0.35 -1.54 -77.27 -1.64 -3.37 -51.34 -5.71 -4.09 39.61
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.35 -1.54 -77.27 -1.64 -3.37 -51.34 -5.71 -4.09 39.61
Equity 225.86 225.86 0.00 225.86 225.86 0.00 225.86 225.86 0.00
PBIDTM(%) -78.38 -429.41 -81.75 -154.17 -239.69 -35.68 -320.12 -256.08 25.01

Celestial Biolabs Share Price

2.43 0.00 (0.00%)
11-Mar-2020 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.